Oligomeric α-synuclein (Human) ELISA Kit

Oligomeric α-synuclein (Human) ELISA Kit 

Catalog Number: ASYN-OL-01-1016

Size: 1 plate (96 wells)

Oligomeric α-Synuclein ELISA Kit is a sandwich enzyme-linked immunoassay for the quantitative determination of oligomeric α-Synuclein with high sensitivity and specificity in CSF.

Oligomeric α-synuclein consists of soluble assemblies of multiple α-synuclein molecules, typically containing 2–20 monomer units. The assay utilizes a selected anti-oligomeric α-synuclein polyclonal antibody that specifically recognizes oligomeric α-synuclein species of various sizes, enabling reliable detection of aggregated α-synuclein forms associated with disease pathology.

Kit Performance

• Sensitivity: 0.5 ng/mL
• Assay Range: 0.5 – 20 ng/mL
• Cross-reactivity: There is no cross reaction found
• Recovery rate: 80 – 120% with normal human CSF samples with known concentrations.
• Precision

(CV (%) = SD/mean X 100)

• Intra-Assay: CV < 20%
• Inter-Assay: CV < 20%

Materials Supplied

List of component

Storage Instruction

The components arrive with ice pack, and must immediately be stored at 2-8°C. The kit components are stable at the date specified in CoA.

Supplementary information

α-Synuclein is a presynaptic neuronal protein involved in synaptic vesicle trafficking and neurotransmitter release. In Parkinson’s disease and related synucleinopathies, α-synuclein undergoes misfolding and aggregation, leading to the formation of Lewy bodies, a pathological hallmark of the disease.

Several α-synuclein species are commonly measured as biomarkers in research and clinical studies, including total α-synuclein, oligomeric α-synuclein, and phosphorylated α-synuclein. Total α-synuclein reflects the overall protein level, while oligomeric α-synuclein represents aggregated soluble forms that are considered the most neurotoxic species and are believed to play a key role in neuronal damage. In addition, phosphorylated α-synuclein at serine 129 is strongly associated with pathological aggregation, as the majority of α-synuclein present in Lewy bodies is phosphorylated at this residue.

Measurement of these different α-synuclein species helps characterize disease pathology, progression, and therapeutic response in Parkinson’s disease studies.